Skip to content

Comparison of Midazolam and Fentanyl for sedation of infants under mechanical ventilation

Comparing the effect of Fentanyl and Midazolam on the Sedation of infants under mechanical ventilation; A Randomized Clinical Trial

Status
Active, not recruiting
Phases
Phase 3
Study type
Interventional
Source
IRCT
Registry ID
IRCT2017082417413N26
Enrollment
60
Registered
2017-09-02
Start date
2016-07-01
Completion date
Unknown
Last updated
2018-02-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Respiratory distress syndrome of newborn. Respiratory distress syndrome of newborn

Interventions

Intervention 1: Second group: Fentanyl 0.5 mcg/kg. Intervention 2: First group: Midazolam 0.1 mg/kg.
Treatment - Drugs
Second group: Fentanyl 0.5 mcg/kg
First group: Midazolam 0.1 mg/kg

Sponsors

Vice Chancellor for Research, Baqiyatallah University of Medical Sciences
Lead Sponsor

Eligibility

Sex/Gender
All
Age
1 Days to 28 Days

Inclusion criteria

Inclusion criteria: Inclusion criteria: Infants between 2.5 and 4 kg of weight who needed intubation and mechanical ventilation Exclusion criteria: Patients lower than 2.5 kg and more than 4 kg; congenital heart disease; brain anomalies; metabolic or chromosomal syndromes

Exclusion criteria

Exclusion criteria:

Design outcomes

Primary

MeasureTime frame
Duration of hospitalization. Timepoint: After Intervention. Method of measurement: Counting hospital stay days.;Duration of Ventilation. Timepoint: After Intervention. Method of measurement: Counting ventilator-dependent days.

Secondary

MeasureTime frame
Pneumothorax. Timepoint: After Intervention. Method of measurement: Plain chest X-ray.

Countries

Iran (Islamic Republic of)

Contacts

Public ContactMohammad Hossein Khosravi

Student Research Committee, Baqiyatallah University of Medical Sciences, Tehran, Iran

dr.mhkhosravi@gmail.com+98 21 8862 0826

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026